Tag: Rituxan

As of 2023, there are three FDA-approved biosimilars for Rituxan (rituximab) available in the United States, offering alternatives for patients and healthcare providers [1.5.3]. If you're asking, 'What is a substitute for RITUXAN?', it's important to understand these biosimilars and other therapeutic options.

In clinical trials for non-Hodgkin's lymphoma, the median time to response was approximately 50 days (about 7 weeks) following a Rituxan infusion. However, the answer to how long does it take for a Rituxan infusion to work varies significantly depending on the treated condition, with some patients noticing improvement much later.

Infusion-related reactions are a very common side effect of Rituxan, with some studies showing they occur in over 80% of patients during the first infusion [1.6.5]. So, what is the most common side effect of Rituxan and what should patients expect?

First approved by the FDA in 1997 for certain lymphomas, rituximab is a medication widely known for its efficacy across various hematologic cancers and autoimmune disorders, leading many to ask: **what class of drug is rituximab infusion**?. It is classified as a monoclonal antibody, a type of targeted therapy that works by harnessing the body's own immune system to fight disease.

The U.S. Food and Drug Administration (FDA) first approved Truxima (rituximab-abbs) in 2018 as a biosimilar to Rituxan [1.3.1]. This raises a critical question for patients and providers: Is Truxima as good as Rituxan? This article examines the evidence.

The first Rituxan infusion typically takes 4 to 6 hours or even longer, primarily due to the slow infusion rate to monitor for potential reactions. Understanding **how long do Rituxan infusions last?** is crucial for proper treatment planning, as subsequent sessions are often significantly shorter.

Rituxan (rituximab) is a monoclonal antibody used to treat certain cancers and autoimmune diseases. However, its use comes with several significant FDA-mandated black box warnings. Understanding What is the black box warning for Rituxan? is critical for patient safety.

According to the American College of Rheumatology, rituximab is a drug used to treat rheumatoid arthritis that has not improved with other medications. It is a biologic that offers a different approach to managing disease activity, especially in patients with moderate to severe active disease who have not responded adequately to TNF antagonists.

Rituximab-induced acute thrombocytopenia (RIAT) is a rare but recognized side effect, with some case reports noting profound drops in platelet counts within days of infusion [1.2.5]. For those asking, 'Can rituximab cause bleeding?', the answer involves understanding its effects on blood components.

Studies show that diarrhea is a common side effect of Rituxan (rituximab), occurring in 10% to 17% of patients being treated for conditions like Non-Hodgkin's Lymphoma [1.2.4]. The question for many patients is, can RITUXAN cause diarrhea that is severe, and how should it be managed?